Administrator Verma Statement on the Administration’s Action to Lower Drug Prices

“President Trump’s bold leadership to lower drug prices is being heard across the nation. Pfizer’s announcement to scale back their recent price increases is a win for all Americans. At CMS, we will continue to increase competition, strengthen negotiations, and lower costs for Medicare and Medicaid beneficiaries. I join Secretary Azar in working with all stakeholders who share the President’s concern for patients and who want to work with us to lower drug prices.”